Home › Pancreatic Cancer › Connecticut
Pancreatic Cancer clinical trials in Connecticut
25 studies for Pancreatic Cancer are looking for participants at sites in Connecticut.
Cities in Connecticut
- New Haven16 studies
- Hartford7 studies
- East Norwalk7 studies
- Norwalk5 studies
- Stamford4 studies
- Bridgeport4 studies
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07090499Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Yale University, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621718A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Hartford Healthcare, Hartford
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Hartford Healthcare, Hartford
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
- Yale University Cancer Center LAO, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07619521Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07349537Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- and 14 more
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Danbury Hospital, Danbury
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- and 13 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328Pancreatic Cancer Early Detection Consortium
- Yale University, New Haven
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Jul 22, 2026 · NCT04970056Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Yale University, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05053971Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Smilow Cancer Hospital (Yale University), New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Stamford Hospital/Bennett Cancer Center, Stamford
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06998940A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- Nuvance Health, Norwalk
RecruitingObservational study
Ages 50 to 90 · All sexes · Updated Apr 13, 2026 · NCT03250078The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Nuvance Health, Norwalk
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT04406831A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
- Yale University, New Haven
- Nuvance Health, Norwalk
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Apr 13, 2026 · NCT03937453A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Hartford Hospital (site 210), Hartford
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774The Cancer of the Pancreas Screening-5 CAPS5)Study
- Yale University, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT02000089Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
- Yale School of Medicine, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 22, 2025 · NCT03492151Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Yale Cancer Center, New Haven
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 6, 2024 · NCT05254171From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.